Key Metrics
4.9
CiteScore
CiteScore
CiteScore measures average citations received per document published in the serial.
< 5
Impact Factor
Impact Factor
Impact factor of a journal is calculated by dividing the number of current year citations to the source items published in that journal during the previous two years.
0.86
5-Year SI
5-year SI
- N/A 2-year SI
- 0.88 Lifetime SI
Scite Index
Scite Index
scite Index is the ratio of citations supporting research which is published in the journal to sum of citations either supporting or contrasting the research published in the journal for the same time period. Minimum 100 supporting citations required.
0.82
SNIP
SNIP
Source Normalized Impact per Paper measures actual citations received relative to citations expected for the serial’s subject field.
Topics Covered
- Cancer
- Lung cancer
- Adjuvant
- Curcumin
- Chemotherapy
- Immunotherapy
- Crizotinib
- Hepatocellular carcinoma
- Overall survival
- Genotype
- Breast cancer
- Dexamethasone
- Neuroendocrine tumors
- Prostate cancer
- Gefitinib
- Respiratory system
- Standard deviation
- Sunlight
- Clinical trial
- Hepatitis B
Journal Specifications
| Overview | |
| Publisher | FUTURE MEDICINE LTD |
| Language | English |
| Frequency | Fortnightly |
| General Details | |
| Language | English |
| Frequency | Fortnightly |
| Publication Start Year | 2005 |
| Publisher URL | Visit website |
| Website URL | Visit website |
Planning to publish in Future Oncology ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Looking for the right journals to submit your mansucript?
Upload your manuscript and get a submission readiness score and other journal recommendations.
Check my PaperRecently Published Papers
-
Full paper
Advances in breast cancer risk modeling: integrating clinics, imaging, pathology and artificial intelligence for personalized risk assessment
- 1 Dec 23
- Future Oncology
-
Full paper
Residual plasma Epstein–Barr virus DNA after intensity-modulated radiation therapy is associated with poor outcomes in nasopharyngeal carcinoma
- 1 Nov 23
- Future Oncology
-
Full paper
Actual situation of decision-making support from medical staff when cancer patients make treatment choices
- 1 Oct 23
- Future Oncology
-
Full paper
Tumor microenvironment in renal cell carcinoma: what is the current impact?
- 4 Jul 23
- Future Oncology
-
Full paper
Effects of genetic polymorphisms of <i>LINC-PINT</i> gene on liver cancer susceptibility in the Chinese Han population
- 1 Jun 23
- Future Oncology
-
Full paper
Corrigendum
- 1 Jun 23
- Future Oncology
Scite analysis
Powered by scite_
4.9k articles received 56.1k citations see all
- 1,430 Supporting
- 53,259 Mentioning
- 188 Contrasting
Editorial notices
- 2 Retractions
- 0 Withdrawals
- 0 Corrections
- 41 Errata
- 0 Expression of Concern
FAQs
How long has Future Oncology been actively publishing?
Future Oncology has been in operation since 2005 till date.
What is the publishing frequency of Future Oncology ?
Future Oncology published with a Fortnightly frequency.
How many articles did Future Oncology publish last years ?
In 2023, Future Oncology published 24 articles.
What is the eISSN & pISSN for Future Oncology ?
For Future Oncology,eISSN is 1744-8301 and pISSN is1479-6694.
What is Citescore for Future Oncology ?
Citescore for Future Oncology is 4.9.
What is SNIP score for Future Oncology ?
SNIP score for Future Oncology is 0.82.
Who is the publisher of Future Oncology ?
FUTURE MEDICINE LTD is the publisher of Future Oncology.